Abstract:Beyond their crucial role in hemostasis, platelets are increasingly recognized as regulators of inflammation. Via modulation of the immune system by direct and indirect interactions with leukocytes, platelets regulate several aspects of tumor-associated pathology. They influence inflammatory processes in cancer at various stages: platelets alter the activation status of the endothelium, recruit leukocytes to tumor sites and attune the inflammatory milieu at sites of primary and metastatic tumors. Patients with cancer show systemic changes of platelet activation. Tumor-associated platelet activation facilitates initiation of the coagulation cascade and constitutes a significant risk for thrombosis. Tumor-activated platelets further contribute to cancer progression by promoting critical processes such as angiogenesis and metastasis. Platelets modulate innate leukocyte effector functions such as antigen presentation by dendritic cells, monocyte recruitment and differentiation or neutrophil extracellular trap formation, which sculpture immune responses but also promote thrombosis and metastasis. On the other hand, responses of the adaptive immune system are also regulated by platelets. They are also involved in T-helper cell 17 differentiation, which represents a double-edged sword in cancer progression, as these cells propagate angiogenesis and immunosuppressive activities but are also involved in recruiting immune cells into tumors and stimulating effector CD8+ T cells. Moreover, platelets fine-tune tumor surveillance processes by modulating natural killer cell-mediated cancer cell recognition and effector functions. This review aims at summarizing the role of platelet-leukocyte interactions in the development and progression of cancer and puts its focus on cancer-related alterations of platelet and leukocyte functions and their impact on cancer pathology.

The dynamic role of platelets in cancer progression and their therapeutic implications

Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy

Emerging roles of platelets in cancer biology and their potential as therapeutic targets

Recent advances in platelet engineering for anti-cancer therapies

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies

Engineered Platelets for Cancer Therapy

The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis

The critical role of platelet in cancer progression and metastasis

Platelets in the Tumor Microenvironment and Their Biological Effects on Cancer Hallmarks

Platelet-Leukocyte Interplay in Cancer Development and Progression

Platelet-inspired Medicine for Tumor Therapyplatelet-Inspired Medicine for Tumor Therapy

Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells

Inhibition of Platelet Function: Does It Offer a Chance of Better Cancer Progression Control?

Interaction Between Circulating Cancer Cells and Platelets: Clinical Implication

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

A role for platelets in metabolic reprogramming of tumor-associated macrophages

Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy

Effects of the interactions between platelets with other cells in tumor growth and progression

The use of platelets as a clinical tool in oncology: opportunities and challenges

Roles of Platelets in Tumor Progression

Cancer progression and tumor hypercoagulability: a platelet perspective